Plasmid DNA was purified from Escherichia coli (DH5α) using Qiagen Miniprep or Maxiprep kits, as appropriate.
Total sample RNA was extracted using commercial kits as appropriate to the sample type; QIAamp Viral RNA Mini spin protocol (Qiagen, Crawley, UK) was used for samples of low cellularity (swabs and BALs), RNeasy Mini kit (Qiagen, Crawley, UK) was used for fresh or frozen tissue samples and RecoverAll™ Total Nucleic Acid Isolation Kit (Applied Biosystems, Warrington, UK) was used for FFPE sections.
Expression of 28S ribosomal RNA, human IL-1Rrp2 (primer pair B), IL-1F8 and IL-1β mRNAs was determined by quantitative real-time PCR on reverse-transcribed samples using a light cycler (Roche Diagnostics, Rotkreuz, Swizerland) with the DNA Master SYBR green I or Fast Start DNA Master SYBR green I kits as appropriate.
Total protein content was determined either with the Bio-Rad Protein Assay kit (Bio-Rad Laboratheies) or the BCA (bicinchoninic acid) Protein Assay Kit (Pierce) as appropriate, using BSA as a standard.
School nurses felt that they could better support students if they could have ready "access" to snacks and testing kits as well as appropriate medical supplies [ 98, 99].
Total protein content was determined either with the Bio-Rad protein assay kit or the BCA protein assay kit (Pierce, Rockford, IL) as appropriate, using BSA as a standard.
Mutations were constructed using the QuikChange II (Agilent Technologies) site-directed mutagenesis kit as previously described using appropriate forward and reverse mutagenic primers in the PCR reaction.
mRNAs were prepared with the mMessage mMachine kit (with cap analog, either SP6- or T7-driven, as appropriate) from Ambion.
Molecular docking studies of these derivatives within c-kit active site as a validated target might be suggested them as appropriate candidates for further efforts toward more potent anticancer compounds.
